ALTOUGH led by the European Commission, the newly announced package of health innovation measures has direct and immediate relevance for the UK healthcare ecosystem. For NHS-facing innovators, technology providers and [...]

Tuberculosis remains one of the most urgent global health challenges, particularly as antimicrobial resistance continues to rise. Traditional diagnostic approaches often struggle to deliver drug-resistance information fast enough to inform [...]

The UK’s health data ecosystem is entering a new phase, one where population health is no longer analysed solely in hindsight, but increasingly anticipated through predictive intelligence. At the centre [...]

The UK’s newborn genomics initiative represents a pivotal shift in how precision diagnostics is delivered, not as a specialist service, but as part of routine clinical care. Through Genomics England’s [...]

Off-the-Shelf Immune Cell Therapy Hunts Down Pancreatic Cancer in Breakthrough Study Scientists have developed an “off-the-shelf” cell therapy that can seek out and destroy aggressive tumour cells, showing remarkable success [...]

FDA Approves New IsoPSA Blood Test to Pinpoint Aggressive Prostate Cancer The FDA has approved a novel blood test called IsoPSA that helps pinpoint aggressive prostate cancer in men over [...]

New Horizons in Targeted Therapeutics and Translational Medicine Advanced AI tools and biomarker innovations are unveiling hidden disease markers at the cellular level, fueling a new wave of precision [...]

Natera is deepening its footprint in precision oncology with the acquisition of Foresight Diagnostics in an all-stock deal worth up to $450 million. This move brings together Natera’s personalised [...]

As we approach 2026, the biotechnology sector is advancing at an unprecedented pace, with five key trends set to shape its future by 2026. The UK, a leader in biotech [...]

The shift from single-gene testing to comprehensive genomic profiling (CGP) is revolutionising disease diagnosis and treatment. Instead of analysing one mutation at a time, CGP examines hundreds simultaneously, revealing [...]